CARRIE HEINEMANN: Open Payments
NPI 1477012474 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 18 payments from 10 companies in 2025. Trend: 2023 $81 · 2024 $823 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $89 |
| BLUEWIND MEDICAL | 3 | $87 |
| Teleflex LLC | 3 | $77 |
| ABBVIE INC. | 2 | $46 |
| 180 Medical, Inc. | 1 | $30 |
| FEMSelect Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
| Boston Scientific Corporation | 2 | $24 |
| Laborie Medical Technologies Corp. | 1 | $18 |
| ConvaTec Inc. | 1 | $16 |
Products named: GEMTESA, SOLESTA, BOTOX, ENPLACE, Veozah, Axonics, Eclipse, CURE CATHETER.
Industry payments across CA — which companies pay providers there.
